and STOCKHOLM, Sweden, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) and Sobi ® (STO:SOBI) today announced the European Medicines Agency (EMA) has validated an ...

The submission includes positive data from the Phase 3 VALIANT study ... systemic pegcetacoplan will receive approval for those indications from the FDA or equivalent foreign regulatory agencies ...

Please purchase a Premium Subscription to continue reading. To continue, please log in, or sign up for a new account. We offer one free story view per month. If you ...

Houston's third-year forward had been out since breaking a bone in his hand during the team shootaraound on Jan. 3.

A little show about big ideas. From the people who make Planet Money, The Indicator helps you make sense of what's happening today. It's a quick hit of insight into work, business, the economy ...

STOCKHOLM, Feb. 20, 2025 /PRNewswire/ -- Sobi® and Apellis Pharmaceuticals today announced the European Medicines Agency (EMA) has validated an indication ... from the Phase 3 VALIANT study.

The objective is to provide guidance for pregnant women and obstetric care and exercise professionals on prenatal physical activity. The outcomes evaluated were maternal, fetal or neonatal morbidity, ...

The UAL Level 3 Diploma and Extended Diploma in Music Performance and Production have been designed to provide students with the skills, knowledge and understanding necessary to progress to further ...

TORONTO — The Delta Air Lines jet came down fast, wobbled so hard that it lost its right wing, and burst into flames on a runway in Toronto. The aircraft slid to a stop, upside down, leaving a ...